Models of deletion for visualizing bacterial variation: an application to tuberculosis spoligotypes

por Reyes, Josephine F, Francis, Andrew R, Tanaka, Mark M
Publicado 2008

Exercise Science Academic Programs and Research in the Philippines

por MADRIGAL, NORBERTO, REYES, JOSEPHINE JOY, PAGADUAN, JEFFREY, ESPINO, REIL VINARD
Publicado 2010

A Model-Based Bayesian Estimation of the Rate of Evolution of VNTR Loci in Mycobacterium tuberculosis

por Aandahl, R. Zachariah, Reyes, Josephine F., Sisson, Scott A., Tanaka, Mark M.
Publicado 2012

Distribution of pomalidomide into semen of healthy male subjects after multiple doses

por Li, Yan, Wang, Xiaomin, Liu, Liangang, Reyes, Josephine, Palmisano, Maria, Zhou, Simon
Publicado 2018

A Phase 1, Open-Label Study in Healthy Subjects to Evaluate the Absolute Bioavailability of AG-221 by a Microtracer Approach

por Wang, Xiaomin, Chen, Jian, Reyes, Josephine, Zhou, Simon, Palmisano, Maria, Li, Yan
Publicado 2019

Lenalidomide at Therapeutic and Supratherapeutic Doses Does Not Prolong QTc Intervals in the Thorough QTc Study Conducted in Healthy Men

por Chen, Nianhang, Ye, Ying, Liu, Liangang, Reyes, Josephine, Assaf, Mahmoud S, Kasserra, Claudia, Zhou, Simon, Palmisano, Maria
Publicado 2013

A Phase I, open-label, randomized, crossover study in healthy subjects to evaluate the bioavailability of, and the food effect on, a pomalidomide oral liquid suspension

por Li, Yan, Liu, Liangang, Huang, Lian, Wang, Xiaomin, Hoffmann, Matthew, Reyes, Josephine, Palmisano, Maria, Zhou, Simon
Publicado 2018

In Vivo Assessment of the Effect of CYP1A2 Inhibition and Induction on Pomalidomide Pharmacokinetics in Healthy Subjects

por Li, Yan, Liu, Liangang, Wang, Xiaomin, Zhang, Chengyue, Reyes, Josephine, Hoffmann, Matthew, Palmisano, Maria, Zhou, Simon
Publicado 2018

An Open‐Label, Phase 1 Study to Assess the Effects of Hepatic Impairment on Pomalidomide Pharmacokinetics

por Li, Yan, Wang, Xiaomin, Liu, Liangang, Zhang, Chengyue, Gomez, Diana, Reyes, Josephine, Palmisano, Maria, Zhou, Simon
Publicado 2018

No clinically significant drug interactions between lenalidomide and P-glycoprotein substrates and inhibitors: results from controlled phase I studies in healthy volunteers

por Chen, Nianhang., Weiss, Daniel, Reyes, Josephine, Liu, Liangang, Kasserra, Claudia, Wang, Xiaomin, Zhou, Simon, Kumar, Gondi, Weiss, Lilia, Palmisano, Maria
Publicado 2014

Erratum to: No clinically significant drug interactions between lenalidomide and P-glycoprotein substrates and inhibitors: results from controlled phase I studies in healthy volunt...

por Chen, Nianhang, Weiss, Daniel, Reyes, Josephine, Liu, Liangang, Kasserra, Claudia, Wang, Xiaomin, Zhou, Simon, Kumar, Gondi, Weiss, Lilia, Palmisano, Maria
Publicado 2014

Absorption, metabolism and excretion of [(14)C]pomalidomide in humans following oral administration

por Hoffmann, Matthew, Kasserra, Claudia, Reyes, Josephine, Schafer, Peter, Kosek, Jolanta, Capone, Lori, Parton, Anastasia, Kim-Kang, Heasook, Surapaneni, Sekhar, Kumar, Gondi
Publicado 2012

Safety, Pharmacokinetics, and Pharmacodynamics of CC‐90001 (BMS‐986360), a c‐Jun N‐terminal Kinase Inhibitor, in Phase 1 Studies in Healthy Participants

por Ye, Ying, Gaudy, Allison, Thomas, Michael, Reyes, Josephine, Burkhardt, Barbara, Horan, Gerald, Liu, Liangang, Chen, Jian, Ghosh, Atalanta, Carayannopoulos, Leonidas N., Tatosian, Daniel A., Palmisano, Maria
Publicado 2022